UK pharmaceutical giant AstraZeneca said it is on course to roll out a variant-resistant Covid-19 vaccine in the autumn this year, as clinical trials begin this spring.
The FTSE 100 company announced the schedule as it unveiled its annual results, Sky News reported on 11 February.
